Lishan Aklog, M.D. Chairman & Chief Executive Officer PAVmed Inc. One Grand Central Place, Suite 4600 New York, NY 10165 Dear Dr. Aklog:Placement Agent Agreement • April 12th, 2019 • PAVmed Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 12th, 2019 Company Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (“Maxim” or the “Placement Agent”) and PAVmed Inc. (the “Company”), that Maxim shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered shares (the “Shares” or the “Securities”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that Maxim would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Placement shall be collectively referred to herein as the “Transacti
Subscription AgreementSubscription Agreement • April 12th, 2019 • PAVmed Inc. • Surgical & medical instruments & apparatus
Contract Type FiledApril 12th, 2019 Company IndustryThis subscription agreement (this “Subscription”) is dated April __, 2019, by and between the investor identified on the signature page hereto (the “Investor”) and PAVmed Inc., a Delaware corporation (the “Company”), whereby the parties agree as follows:
VOTING AGREEMENTVoting Agreement • April 12th, 2019 • PAVmed Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 12th, 2019 Company Industry JurisdictionVOTING AGREEMENT, dated as of April __, 2019 (this “Agreement”), by and between PAVmed Inc., a Delaware corporation with offices located at One Grand Central Place, Suite 4600, New York, NY 10165 (the “Company”) and the person listed on the signature page hereto (the “Stockholder”).